TEDA VC
泰达科投
TEDA VC (泰达科投) is an active Chinese venture capital firm that has been investing across biotech, semiconductor, and advanced manufacturing since at least 2021. It appears as both a follower and a lead investor: it followed in Shize Biotech's angel round in 2021 and participated in CoreX Technology's funding in 2023, then co-led a Series A1 round in physical intelligence startup FeiJieKeSi in August 2026 alongside Haison Capital and Fudan Sci-Tech Innovation . The firm also doubled down on portfolio companies, with its partners re-upping in Shize Biotech's later round . Elsewhere's corpus does not cover its founding date, AUM, or full team composition.
AI-generated — may contain errors, please verify.
Coverage
Yunqi Partners | Physical intelligence startup "FeiJieKeSi" raises hundreds of millions of RMB in Series A1, with Yunqi Capital increasing its stake
Building a Solid Foundation for Domestic Physics-Based AI Technology
Machenike Closes Over 100 Million RMB Series B+ Round | BlueRun Ventures
Building the Next Generation of ADAS Advanced Driver-Assistance Systems
Chip/Consumer Electronics/Gene Editing Firms Raise New Funding; Quantum Computers, Micro-Display Chips Achieve Global Leadership | Rongbao · April
Targeting international advanced standards.
Advanced packaging substrate supplier **XinAi Technology** (芯爱科技) has raised over **500 million yuan** in its Series A1 funding round.
We aim to achieve domestic production and supply chain independence in the high-end substrate space.
7 Companies Raised Nearly 1.5 Billion Yuan, 4 Valued Above 1 Billion Yuan | FreeS Family Funding News · September
Every step of growth for an innovative company: from 0 to 1, from 1 to 10, and from 10 to 100
FreeS Family Funding News · June | Saturnbird, Shize Biotech, and Light Travel Secure Funding
We also released two short videos this week — follow us to check them out.





